A Study of Cetuximab(Erbitux) With Cisplatin and Capecitabine(Xeloda)as 1st Line Treatment in the Advanced Gastric Cancer
Clinical trial NCT00477711 · COMPLETED
Trial details
- NCT number
- NCT00477711
- Sponsor
- Peking University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-03-01
- Primary completion
- 2008-12-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.